CN106831639B - The preparation method of Cefcapene side-chain acid - Google Patents

The preparation method of Cefcapene side-chain acid Download PDF

Info

Publication number
CN106831639B
CN106831639B CN201611267418.4A CN201611267418A CN106831639B CN 106831639 B CN106831639 B CN 106831639B CN 201611267418 A CN201611267418 A CN 201611267418A CN 106831639 B CN106831639 B CN 106831639B
Authority
CN
China
Prior art keywords
added
reacted
cefcapene
preparation
chain acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201611267418.4A
Other languages
Chinese (zh)
Other versions
CN106831639A (en
Inventor
郑庚修
邱化齐
孙智源
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANDONG JINCHENG KERUI CHEMICAL CO Ltd
Original Assignee
SHANDONG JINCHENG KERUI CHEMICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANDONG JINCHENG KERUI CHEMICAL CO Ltd filed Critical SHANDONG JINCHENG KERUI CHEMICAL CO Ltd
Priority to CN201611267418.4A priority Critical patent/CN106831639B/en
Publication of CN106831639A publication Critical patent/CN106831639A/en
Application granted granted Critical
Publication of CN106831639B publication Critical patent/CN106831639B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

The present invention relates to a kind of preparation methods of Cefcapene side-chain acid, belong to medicine intermediate technical field.The preparation method is that ketene dimer is added into alcohol organic solvent under nitrogen protection, then bromine is added dropwise to be reacted, the mixed liquor quenching reaction of methylene chloride and water is added, separate organic phase, acetic acid is added into organic phase, propionic aldehyde is added dropwise simultaneously after cooling and organic alkali catalyst A is reacted, then thiocarbamide is added to be reacted, it is concentrated through vacuum distillation, methylene chloride is added into concentrate, di-tert-butyl dicarbonate and organic alkali catalyst B are reacted, then liquid alkaline is added to be reacted, hydrochloric acid is added dropwise after cooling and carries out crystallization, through filtering, isopropanol water solution elution, (Z) -2- (2- t-butoxycarbonyl amino thiazole-4-yl) -2- penetenoic acid is obtained after drying, that is Cefcapene side-chain acid.The present invention is using ketene dimer as starting material, and side reaction is few, high income, and obtained product purity is high, and reaction condition is mild, is more easy to realize industrial production.

Description

The preparation method of Cefcapene side-chain acid
Technical field
The present invention relates to a kind of preparation methods of Cefcapene side-chain acid, belong to medicine intermediate technical field.
Background technique
The pivaloyl oxygen methyl esters of Cefcapene (S-1006) is researched and developed by Yan Yeyi company of Japan, in 1997 with Flomox Trade name Initial Public Offering.Method of cefcapene pivoxil is the orally available cephalosporin analog antibiotic of the third generation, and pharmacological research shows to aerobic G+ bacterium MSSA MIC80 be 3.13 μ g/mL, the μ of MIC80≤0.1 g/ identical as Cefotiam, Cefaclor, to streptococcus pneumonia ML is better than Cefaclor, suitable with Cefditoren, very to the activity of the streptococcus pneumonia of penicillin resistant (contain moderate drug resistance) By force, MIC80 is 0.78 μ g/mL;To citrobacter freundii, enterobacter cloacae, providencia rettgeri, the mucous membrane in G- bacterium Scorching Branhamella catarrhalis, the activity of serratia marcescens are stronger than Cefditoren, Cefotiam;It is bloodthirsty to Proteus, influenza Bacillus, morganella morganii strain, the activity of gonococcus are stronger than Cefaclor, Cefotiam, suitable with Cefteram;To resistant to ammonia benzyl west The haemophilus influenzae of woods has very strong activity, and MIC80 is 0.05 μ g/mL;Activity to anaerobic bacteria be comparison medicine in it is strongest, Dosage is small.
Entitled (Z) -2- (2- t-butoxycarbonyl amino the thiazole-4-yl) -2- penta of chemistry of Cefcapene side-chain acid (BTPA) Olefin(e) acid, molecular formula C13H18N2O4S, molecular weight 298.36, BTPA are the important intermediate for synthesizing Cefcapene, synthesis side Method be usually using ethyl acetoacetate as starting material, etherified, bromination, cyclization, hydrolysis and etc. synthesize, can also first bromine Change, it is rear to be etherified, but all there is a problem of that side reaction is more, yield is low.Its reaction equation is as follows:
Summary of the invention
The object of the present invention is to provide a kind of preparation methods of Cefcapene side-chain acid, solve traditional synthesis presence Side reaction is more, problem that product yield is low, have the characteristics that side reaction occur less, product yield it is high.
The preparation method of Cefcapene side-chain acid of the present invention, comprising the following steps:
(1) 4- acetyl bromide acetic acid esters is prepared:
Under nitrogen protection, ketene dimer is added into alcohol organic solvent, bromine is then added dropwise and is reacted, is added two The mixed liquor quenching reaction of chloromethanes and water separates organic phase to get 4- acetyl bromide acetic acid esters is arrived;
(2) (Z) -2- (thiazolamine -4- base) -2- pentenoate is prepared:
Acetic acid is added into organic phase, propionic aldehyde is added dropwise simultaneously after cooling and organic alkali catalyst A is reacted, is then added Thiocarbamide is reacted, and is concentrated through vacuum distillation, obtains (Z) -2- (thiazolamine -4- base) -2- pentenoate;
(3) Cefcapene side-chain acid is prepared:
Methylene chloride, di-tert-butyl dicarbonate and organic alkali catalyst B are added into concentrate to be reacted, is then added Liquid alkaline is reacted, and hydrochloric acid is added dropwise after cooling and carries out crystallization, obtains (Z) -2- after filtering, isopropanol water solution elution, drying (2- t-butoxycarbonyl amino thiazole-4-yl) -2- penetenoic acid, i.e. Cefcapene side-chain acid.
Wherein it is preferred to which technical solution is as follows:
Alcohol organic solvent is the fatty alcohol of C1~C6, preferably methanol or ethyl alcohol in step (1).
Ketene dimer in step (1), bromine, alcohol organic solvent molar ratio be 1:1~1.1:6~12.
The mass ratio of alcohol organic solvent, methylene chloride, water in step (1) is 1:1:1.5~2.
Alcohol organic solvent is cooled to after -30~-20 DEG C in step (1), ketene dimer is added, bromine is added dropwise and carries out instead 0~10 DEG C of seasonable reaction temperature, reaction time 1h.
Cooling temperature is -20~-10 DEG C in step (2);It is 20~30 DEG C that reaction temperature when thiocarbamide is reacted, which is added, Reaction time is 1h;Vapo(u)rizing temperature≤10 DEG C when vacuum distillation.
Organic alkali catalyst A is the mixture of piperidines and pyridine in step (2), and the molar ratio of piperidines and pyridine is 1:0.5 ~1.
Organic alkali catalyst B in step (3) is pyridine or 4-N, N- dimethyl aminopyridine.
Reaction temperature when methylene chloride, di-tert-butyl dicarbonate and organic alkali catalyst B are reacted is added in step (3) Degree is 30~40 DEG C, reaction time 8h;It is 60~80 DEG C that reaction temperature of liquid alkaline when being reacted, which is added, and the reaction time is 4h。
The concentration of isopropanol water solution is 30~40wt% in step (3).
The following are the typical chemical equations of the present invention:
Beneficial effects of the present invention are as follows:
Preparation method of the invention is using ketene dimer as starting material, and side reaction is few, high income, at low cost, obtains Product purity it is high, reaction condition is mild, easy to operate, it is easier to realize industrialized production.
Specific embodiment
The present invention is described further with reference to embodiments.
Embodiment 1
The preparation of 4- acetyl bromide acetic acid esters:
64mL (1.6mol) methanol is added in the three-necked flask that the capacity equipped with blender and thermometer is 500mL ,- Ketene dimer 16.8g (0.2mol) is added at 20 DEG C, is added dropwise bromine 33.6g (0.21mol), temperature is maintained at -30~-25 DEG C, It is added dropwise in 2h, is warming up to 0~5 DEG C, insulation reaction 1h, 39mL methylene chloride and 100mL water, stirring 5 is added in end of reaction Organic phase is separated after minute to get 4- acetyl bromide acetic acid esters is arrived, through liquid-phase chromatographic analysis, purity 97.5%;
(Z) preparation of -2- (thiazolamine -4- base) -2- pentenoate:
1.2g (0.02mol) acetic acid is added into organic phase, 15.9g is added dropwise simultaneously at a temperature of -20~-15 DEG C The organic alkali catalyst A (0.22mol) positive propionic aldehyde and be made of 0.8g (0.01mol) pyridine and 0.86g (0.01mol) piperidines, 2h or more is dripped off, and 16.7g (0.22mol) thiocarbamide is added, is rapidly heated to 25~30 DEG C, and addition 60mL aqueous solution is washed after keeping the temperature 1h It washs twice, is down to 10 DEG C or less reduced pressures, obtain 36.2g (Z) -2- (thiazolamine -4- base) -2- pentenoate, yield 85.3%, through liquid-phase chromatographic analysis, purity 98.5%;
(Z) preparation of -2- (2- t-butoxycarbonyl amino thiazole-4-yl) -2- penetenoic acid:
17g methylene chloride, bis- dimethyl dicarbonate of 40.8g are added into (Z) -2- (thiazolamine -4- base) -2- pentenoate Butyl ester, 0.7g pyridine react 8 hours at 30~35 DEG C, and addition 22.6g concentration is 30wt% liquid alkaline, 60mL water, it is warming up to 65~ Hydrochloric acid crystallization is added dropwise at 30~35 DEG C in 70 DEG C of reaction 4h, then filtering is drenched with the isopropanol water solution that 40mL concentration is 30wt% It washes, it is dry, obtain 47.8g Cefcapene side-chain acid, yield 80.2%, through liquid-phase chromatographic analysis, purity 99.3%.
Embodiment 2
The preparation of 4- acetyl bromide acetic acid esters:
93mL (1.6mol) ethyl alcohol is added in the three-necked flask that the capacity equipped with blender and thermometer is 500mL ,- 20 DEG C or less addition ketene dimer 16.8g (0.2mol) are added dropwise bromine 35.2g (0.22mol), -30~-25 DEG C of temperature holding, and 2 It is added dropwise in hour, is warming up to 0~5 DEG C, insulation reaction 1h, end of reaction is added 39mL methylene chloride and 100mL water, stirs It mixes and separates within 5 minutes organic phase to get 4- acetyl bromide acetic acid esters is arrived, through liquid-phase chromatographic analysis, purity 98.0%;
(Z) preparation of -2- (thiazolamine -4- base) -2- pentenoate:
1.2g (0.02mol) acetic acid is added into organic phase, 17.3g is added dropwise simultaneously at a temperature of -20~-15 DEG C The organic alkali catalyst A (0.24mol) positive propionic aldehyde and be made of 0.8g (0.01mol) pyridine and 0.86g (0.01mol) piperidines, 2h or more is dripped off, and 18.2g (0.24mol) thiocarbamide is added, is rapidly heated to 25~30 DEG C, and the washing of 60mL aqueous solution is added in heat preservation 1h Twice, 10 DEG C or less reduced pressures are down to, 37.0g (Z) -2- (thiazolamine -4- base) -2- pentenoate, yield are obtained 87.2%, through liquid-phase chromatographic analysis, purity 98.9%;
(Z) preparation of -2- (2- t-butoxycarbonyl amino thiazole-4-yl) -2- penetenoic acid:
17g methylene chloride, bis- dimethyl dicarbonate of 44.5g are added into (Z) -2- (thiazolamine -4- base) -2- pentenoate Butyl ester, 0.7g pyridine react 8 hours at 30~35 DEG C, and liquid alkaline, 60mL water that 22.6g concentration is 30wt% is added, is warming up to 65 ~70 DEG C of reaction 4h, 30~35 DEG C of dropwise addition hydrochloric acid crystallizations, filtering, the isopropanol water solution that then 40mL concentration is 30wt% drench It washes, it is dry, obtain 48.6g Cefcapene side-chain acid, yield 81.4%, through liquid-phase chromatographic analysis, purity 99.5%.

Claims (9)

1. a kind of preparation method of Cefcapene side-chain acid, it is characterised in that: the following steps are included:
(1) under nitrogen protection, ketene dimer is added into alcohol organic solvent, bromine is then added dropwise and is reacted, is added two The mixed liquor quenching reaction of chloromethanes and water, separates organic phase;
(2) acetic acid is added into organic phase, propionic aldehyde is added dropwise simultaneously after cooling and organic alkali catalyst A is reacted, is then added Thiocarbamide is reacted, and is concentrated through vacuum distillation;
(3) methylene chloride, di-tert-butyl dicarbonate and organic alkali catalyst B are added into concentrate to be reacted, are then added Liquid alkaline is reacted, and hydrochloric acid is added dropwise after cooling and carries out crystallization, obtains cephalo card after filtering, isopropanol water solution elution, drying Product side-chain acid;
Organic alkali catalyst A is the mixture of piperidines and pyridine in step (2), and the molar ratio of piperidines and pyridine is 1:0.5~1.
2. the preparation method of Cefcapene side-chain acid according to claim 1, it is characterised in that: there is alcohols in step (1) Solvent is the fatty alcohol of C1~C6.
3. the preparation method of Cefcapene side-chain acid according to claim 1, it is characterised in that: double ethylene in step (1) Ketone, bromine, alcohol organic solvent molar ratio be 1:1~1.1:6~12.
4. the preparation method of Cefcapene side-chain acid according to claim 1, it is characterised in that: the alcohols in step (1) Organic solvent, methylene chloride, water mass ratio be 1:1:1.5~2.
5. the preparation method of Cefcapene side-chain acid according to claim 1, it is characterised in that: by alcohols in step (1) Ketene dimer is added in organic solvent after being cooled to -30~-20 DEG C, be added dropwise 0~10 DEG C of reaction temperature when bromine is reacted, instead It is 1h between seasonable.
6. the preparation method of Cefcapene side-chain acid according to claim 1, it is characterised in that: cooling temperature in step (2) Degree is -20~-10 DEG C;It is 20~30 DEG C that reaction temperature when thiocarbamide is reacted, which is added, reaction time 1h;When vacuum distillation Vapo(u)rizing temperature≤10 DEG C.
7. the preparation method of Cefcapene side-chain acid according to claim 1, it is characterised in that: organic in step (3) Base catalyst B is pyridine or 4-N, N- dimethyl aminopyridine.
8. the preparation method of Cefcapene side-chain acid according to claim 1, it is characterised in that: two are added in step (3) Reaction temperature when chloromethanes, di-tert-butyl dicarbonate and organic alkali catalyst B are reacted is 30~40 DEG C, and the reaction time is 8h;It is 60~80 DEG C that reaction temperature when liquid alkaline is reacted, which is added, reaction time 4h.
9. the preparation method of Cefcapene side-chain acid according to claim 1, it is characterised in that: isopropanol in step (3) The concentration of aqueous solution is 30~40wt%.
CN201611267418.4A 2016-12-31 2016-12-31 The preparation method of Cefcapene side-chain acid Active CN106831639B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611267418.4A CN106831639B (en) 2016-12-31 2016-12-31 The preparation method of Cefcapene side-chain acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611267418.4A CN106831639B (en) 2016-12-31 2016-12-31 The preparation method of Cefcapene side-chain acid

Publications (2)

Publication Number Publication Date
CN106831639A CN106831639A (en) 2017-06-13
CN106831639B true CN106831639B (en) 2019-03-19

Family

ID=59117246

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611267418.4A Active CN106831639B (en) 2016-12-31 2016-12-31 The preparation method of Cefcapene side-chain acid

Country Status (1)

Country Link
CN (1) CN106831639B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110143873A (en) * 2019-06-20 2019-08-20 济南大学 A kind of method of the intermediate 4- acetyl bromide methyl acetate of micro- reaction synthesis Method of cefcapene pivoxil side-chain acid
CN112321444A (en) * 2020-09-17 2021-02-05 江西邦浦医药化工有限公司 Synthesis method of 4-bromo-3-oxo-N-phenylbutanamide
CN113025679B (en) * 2021-03-17 2023-04-28 石药集团内蒙古中诺药业有限公司 Enzymatic preparation process of cefcapene precursor acid of t-butyloxycarbonyl

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1058595A (en) * 1990-07-19 1992-02-12 盐野义制药株式会社 Thioalkylthio cephalosporin derivatives
CN101007793A (en) * 2007-01-22 2007-08-01 山东汇海医药化工有限公司 Method for preparation of EHATA
CN101182314A (en) * 2007-11-30 2008-05-21 山东金城医药化工有限公司 Method for preparing 2-(2-butoxy carbonyl amino thiazole-4-group)-2-pentenoic acid ester
CN103193731A (en) * 2012-01-09 2013-07-10 华东理工大学 Preparation method of cis-2-(2-tertbutoxy formamido thiazole-4-base)-2-pentenoic acid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1058595A (en) * 1990-07-19 1992-02-12 盐野义制药株式会社 Thioalkylthio cephalosporin derivatives
CN101007793A (en) * 2007-01-22 2007-08-01 山东汇海医药化工有限公司 Method for preparation of EHATA
CN101182314A (en) * 2007-11-30 2008-05-21 山东金城医药化工有限公司 Method for preparing 2-(2-butoxy carbonyl amino thiazole-4-group)-2-pentenoic acid ester
CN103193731A (en) * 2012-01-09 2013-07-10 华东理工大学 Preparation method of cis-2-(2-tertbutoxy formamido thiazole-4-base)-2-pentenoic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
stereoselective or Exclusive Synthesis of Ethyl (Z)-2-(2-Substituted-thiazol-4-yl)pent-2-enoates from Ethyl (E/Z)-2-(2-Bromoacetyl)pent-2-enoate;Jiao-Jiao Zhai, et al.,;《Synlett》;20130605;第24卷;第1399-1404页

Also Published As

Publication number Publication date
CN106831639A (en) 2017-06-13

Similar Documents

Publication Publication Date Title
JP5774732B2 (en) Method for the synthesis of moxifloxacin hydrochloride
CN106831639B (en) The preparation method of Cefcapene side-chain acid
WO2015055127A1 (en) (r)-praziquantel preparation method
EA026617B1 (en) Process for the preparation of (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)acetic acid esters
CN112062712A (en) Preparation method of 2- (5-bromo-3-methylpyridin-2-yl) acetic acid hydrochloride
CA2719526A1 (en) Conversion of tryptophan into .beta.-carboline derivatives
CN107118215B (en) A kind of preparation method for treating breast cancer medicines Rui Boxini intermediate
CN105968040B (en) A kind of preparation method of Lei Dipawei intermediate
CN105254629B (en) A kind of preparation method of moxifloxacin hydrochloride
CN107365301B (en) Synthesis method of crizotinib and preparation method of intermediate thereof
CN109796457A (en) A kind of preparation method and applications of 2- (3- (azetidine -3- base) piperidin-1-yl) ethyl -1- alcohol
WO2015087343A2 (en) An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof
KR20160027536A (en) Process for preparing an intermediate useful for the synthesis of silodosin
CN109265385B (en) Synthesis process of chiral catalyst
CN103804265B (en) The synthesis of a kind of Sulpiride or its optical isomer and post-processing approach
CN108203396B (en) Synthesis of enkephalinase inhibitor
US20130085278A1 (en) Methods for the preparation of 5-[2-[7 (trifluoromethyl)-5-[4- (trifluoromethyl)phenyl]pyrazolo [1,5-a]pyrimidin-3-yl]ethynyl]-2-pyridinamine
KR101694262B1 (en) Process for preparing crystalline forms of silodosin
CN110128340B (en) Synthesis method of quinolinone compounds
CN110615751A (en) Preparation method of 2-oxo-thiopropionamide
JP5419570B2 (en) Method for purifying 2-acetylaminomethyl-4- (4-fluorobenzyl) morpholine
CN107698533A (en) A kind of method for preparing Linezolid
CN115784978B (en) Method for synthesizing 2-amino-6-bromopyridine
CN115677456B (en) Preparation method of cannabidiol
CN108329332A (en) A method of preparing Glecaprevir

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant